Stephen Ansell, Roxana Dronca, Alan Bryce named to executive roles at Mayo Clinic in the Midwest, Florida, and Arizona

Mayo Clinic researchers have developed a promising way to deliver treatment directly to cholangiocarcinoma tumors, a rare and aggressive bile duct cancer with limited treatment options, using milk-derived nanoparticles that act like guided delivery vehicles. The study points to a potential targeted genetic therapy designed to attack cancer cells while sparing healthy tissue.